Peter L. Collins
63Patents
14h-index
56Co-inventors
87Inventor score
Filing activity: Jul 13, 1988 → Sep 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5149650A | Vaccines for human respiratory virus | Chemistry; Metallurgy | 73 | Expired |
| US6790449B2 | Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins | Chemistry; Metallurgy | 50 | Expired |
| US5993824A | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences | Chemistry; Metallurgy | 38 | Expired |
| US7589180B2 | Specific binding proteins and uses thereof | Chemistry; Metallurgy | 37 | Expired |
| US6264957A | Product of infectious respiratory syncytial virus from cloned nucleotide sequences | Chemistry; Metallurgy | 37 | Expired |
| US6270958A | Detection of negative-strand RNA viruses | Emerging Cross-Sectional Technologies | 30 | Expired |
| US7846455B2 | Attenuated chimeric respiratory syncytial virus | Chemistry; Metallurgy | 29 | Expired |
| US6713066B1 | Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 | Chemistry; Metallurgy | 25 | Expired |
| US6699476B1 | Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules | Chemistry; Metallurgy | 24 | Expired |
| US6689367B1 | Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences | Chemistry; Metallurgy | 24 | Expired |
| US7208161B1 | Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences | Chemistry; Metallurgy | 22 | Expired |
| US7704509B2 | Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens | Chemistry; Metallurgy | 18 | Expired |
| US7709007B2 | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences | Chemistry; Metallurgy | 15 | Active |
| US9937196B2 | Genomic sequence of avian paramyxovirus type 2 and uses thereof | Chemistry; Metallurgy | 15 | Active |
| US7192593B2 | Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens | Chemistry; Metallurgy | 14 | Expired |
| US6410023B1 | Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene | Chemistry; Metallurgy | 13 | Expired |
| US7250171B1 | Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein | Chemistry; Metallurgy | 13 | Expired |
| US6923971B2 | Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes | Chemistry; Metallurgy | 9 | Expired |
| US7704491B2 | Recombinant human metapneumovirus and its use | Chemistry; Metallurgy | 9 | Expired |
| US7951383B2 | Attenuated parainfluenza virus (PIV) vaccines | Chemistry; Metallurgy | 9 | Active |
| US7201907B1 | Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines | Chemistry; Metallurgy | 7 | Expired |
| US7485440B2 | Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 | Chemistry; Metallurgy | 7 | Expired |
| US9957486B2 | Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization | Chemistry; Metallurgy | 7 | Active |
| US7622123B2 | Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines | Chemistry; Metallurgy | 6 | Expired |
| US7244558B1 | Production of novel Newcastle disease virus strains from cDNAs and improved live attenuated Newcastle disease vaccines | Chemistry; Metallurgy | 6 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.